|
Verzögert
Andere Börsenplätze
|
% 5 Tage | Veränd. 1. Jan. | ||
| 8.500 USD | -.--% |
|
-.--% | - |
| 01.10.24 | Eiger BioPharmaceuticals beantragt Konkurs nach Chapter 11 und Liquidationsplan tritt in Kraft | CI |
| 30.09.24 | Eiger BioPharmaceuticals, Inc. hat sein Geschäft aufgegeben | CI |
Hauptkonkurrenten
| % | % 5 Tage | Veränd. 1 Monat | Veränd. 3 Monate | % 1. Jan. | % 1 Jahr | Veränd. 3 Jahre | Veränd. 5 Jahre | Veränd. 10 Jahre | Kap.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -.--% | -.--% | -.--% | -.--% | -.--% | -.--% | -53.55% | -96.69% | -98.40% | 12.59 Mio. | |
| -0.72% | +2.71% | -1.81% | +19.13% | +6.99% | +5.66% | +15.52% | -20.04% | +210.36% | 50.03 Mrd. | |
| -0.69% | +6.25% | +11.74% | +42.59% | +158.07% | +492.36% | +585.40% | +664.13% | - | 44.36 Mrd. | |
| +0.08% | +11.23% | +18.20% | +15.61% | +18.25% | +23.99% | +81.74% | +28.44% | +1’206.44% | 40.82 Mrd. | |
| +0.76% | +6.85% | +17.48% | +40.50% | +8.18% | +35.40% | +10.92% | -0.29% | +217.71% | 39.83 Mrd. | |
| +4.73% | +15.53% | +20.15% | +11.40% | +22.11% | +26.95% | +54.62% | -5.17% | +166.27% | 32.51 Mrd. | |
| -0.41% | +4.08% | -4.02% | +6.66% | - | - | - | - | - | 16.85 Mrd. | |
| +0.51% | +5.29% | +14.20% | +45.10% | +7.81% | +34.62% | +126.87% | +255.80% | - | 16.81 Mrd. | |
| -0.20% | +3.19% | +1.36% | +17.80% | +12.02% | +5.18% | +18.55% | -38.46% | +86.33% | 14.05 Mrd. | |
| +1.81% | +20.45% | +22.74% | +67.40% | +41.37% | +89.35% | +31.49% | -29.37% | +238.66% | 13.22 Mrd. | |
| -0.28% | +5.57% | -0.31% | +39.19% | -9.13% | +3.68% | -35.92% | -29.92% | +114.32% | 12.81 Mrd. | |
| +1.19% | +31.94% | +40.22% | +74.90% | +67.39% | +67.57% | +55.98% | -49.49% | - | 11.55 Mrd. | |
| +0.04% | +0.08% | +1.11% | +52.15% | +22.68% | +43.87% | -14.50% | -37.65% | +158.56% | 11.24 Mrd. | |
| -0.99% | +2.52% | -10.50% | +4.27% | -8.64% | +82.12% | +573.19% | +301.46% | +2’452.20% | 11.06 Mrd. | |
| +1.01% | +19.55% | +17.84% | +11.71% | +25.77% | +724.65% | +2’146.55% | +64.20% | - | 10.25 Mrd. | |
| +0.03% | +0.37% | +0.65% | +59.21% | +78.44% | +288.72% | +521.55% | - | - | 10.11 Mrd. | |
| +1.14% | +18.36% | -0.43% | +14.92% | -5.69% | -8.43% | - | - | - | 9.93 Mrd. | |
| -1.14% | +9.19% | +14.17% | +43.28% | +69.78% | +175.89% | +684.19% | +208.94% | - | 9.71 Mrd. | |
| -2.67% | +0.64% | -2.34% | -26.48% | -29.95% | +35.70% | +37.79% | +45.04% | +54.37% | 9.46 Mrd. | |
| -2.74% | +0.76% | +2.92% | +30.71% | -9.90% | -15.61% | -12.64% | -25.21% | +37.55% | 9.07 Mrd. | |
| Durchschnitt | +0.11% | +183.13% | +8.17% | +28.50% | +25.03% | +111.14% | +268.21% | +72.69% | +403.70% | 18.68 Mrd. | |
| Gewichteter Durchschnitt nach Marktkapitalisierung | +0.35% | +244.35% | +9.90% | +28.89% | +33.98% | +116.63% | +217.97% | +111.80% | +448.33% |
- Börse
- Aktien
- A3EKZU Aktie
- Sektor Eiger BioPharmaceuticals
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
